Clinical trial
Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in…
NCT00403624 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00403624 |
|---|---|
| Title | Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer |
| Official title | Clinical Study to Evaluate a Protocol of Oxaliplatin -UFT- Radiotherapy for the Neoadjuvant Treatment Rectal Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Neoplasms |
| Intervention type | Drug |
| Interventions | OXALIPLATIN |
| Enrollment | 38 |
| Start date | Jul 1, 2001 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Nov 27, 2006 |
| Last update posted | Aug 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: